Sex-different and growth hormone-regulated expression of microRNA in rat liver
© Cheung et al; licensee BioMed Central Ltd. 2009
Received: 06 May 2008
Accepted: 23 February 2009
Published: 23 February 2009
MicroRNAs (miRNAs) are short non-coding RNAs playing an important role in post-transcriptional regulation of gene expression. We have previously shown that hepatic transcript profiles are different between males and females; that some of these differences are under the regulation of growth hormone (GH); and that mild starvation diminishes some of the differences. In this study, we tested if hepatic miRNAs are regulated in a similar manner.
Using microarrays, miRNA screening was performed to identify sex-dependent miRNAs in rat liver. Out of 324 unique probes on the array, 254 were expressed in the liver and eight (3% of 254) of those were found to be different between the sexes. Among the eight putative sex-different miRNAs, only one female-predominant miRNA (miR-29b) was confirmed using quantitative real-time PCR. Furthermore, 1 week of continuous GH-treatment in male rats reduced the levels of miR-451 and miR-29b, whereas mild starvation (12 hours) raised the levels of miR-451, miR-122a and miR-29b in both sexes. The biggest effects were obtained on miR-29b with GH-treatment.
We conclude that hepatic miRNA levels depend on the hormonal and nutritional status of the animal and show that miR-29b is a female-predominant and GH-regulated miRNA in rat liver.
MicroRNAs (miRNAs) are short RNAs of 19–25 base pairs in length. In the latest release of miRBase (11.0, April 2008), a sequence database of miRNA hosted by the Sanger Institute http://microrna.sanger.ac.uk/, there are 678 identified and known miRNAs in human, 472 in mouse and 287 in rat. Most of the well-defined miRNAs are highly conserved across species, suggesting their importance in cellular regulation. These small RNAs are processed from precursor molecules that are either transcribed as ordinary genes (pri-miRNA) or generated as by-products from splicing. The maturation takes place in the cytoplasm when the miRNAs are assembled into miRNA-ribonuclear protein complexes, which in turn selectively bind to a target mRNA and modulate its translatability. At least five possible mechanisms for this miRNA-dependent regulation of translation have been suggested [2, 3]. If the sequences of the miRNA and the target mRNA are a perfect match it will i) trigger endonucleic cleavage. If the sequences are an imperfect match the miRNA will instead ii) inhibit translation by promoting deadenylation of the poly(A) tail, or iii) promote degradation of the nascent peptide, or iv) repress the assembly of ribosomal complex for translation initiation, or v) reduce the speed of the elongation process. Independently of their mechanisms of action, they play a role in gene regulation by negatively affecting mRNA expression and translation.
Some miRNAs are ubiquitous, such as let-7b and miR-22 , while others are highly tissue specific. miR-1a is heart-specific and miR-124a is exclusively found in nervous tissues such as brain and spinal cord [4, 5]. miR-122a is abundant in liver, where it contributes with 70% of the total pool of hepatic miRNA. Studies have shown that miR-122a is a regulator of hepatic lipid metabolism, since inhibition of this miRNA lowers the serum cholesterol levels in normal mice and mice with diet-induced obesity. At the cellular level, miR-122a increases hepatic fatty acid oxidation and decreases lipogenesis . Although the molecular mechanisms behind these effects are still unclear, these findings have paved the way for a new concept within the field of metabolic research.
The liver is a major metabolic organ, handling the metabolism of exogenous and endogenous compounds. We and others have shown that male and female rat livers differ regarding gene expression and metabolism [7–10]. We have previously shown that genes involved in hepatic lipid metabolism are regulated by sex and hormones [11–13] as well as nutrient availability . Based on microarray-generated hepatic transcript profiles, approximately 30% of the sex-differentiated hepatic gene products were shown to be under the control of growth hormone (GH) , and others have shown that the sex-different secretory pattern of GH in rats are mediating at least some of these effects [14–16]. Nothing is known about sex-differences in miRNA levels or if they vary depending on hormonal or nutritional status. In this study, we tested the possibility that miR-122a or other miRNAs from rat liver are expressed differently between males and females and if they are regulated by GH or starvation.
Sex-differences in hepatic miRNA profiles
Sex-differently expressed miRNAs in rat liver
miRNA ratios comparing individual female and male livers (n = 4)
Hormonal and nutritional regulation of hepatic miRNA
In this study, a miRNA screening was performed to identify sex-dependent miRNAs in rat liver. Among eight putative sex-different miRNAs, at least one female-predominant miRNA (miR-29b) could be confirmed using qRT-PCR. In contrast, the candidates for male-predominant miRNA could not be confirmed. In order not to miss any putative sex-dependent miRNA, a relatively high false discovery rate (q < 10%) and low cut-off (1.5) regarding differences between male and female expression levels were used. Moreover, the chemistry for detection by microarray and qRT-PCR are different. These might explain the inconsistent results between microarray and qRT-PCR, and stresses the importance of validating results obtained in this type of screening experiments.
miR-122a might be another female-predominant miRNA in rat liver, since significantly higher (7.4 times, p = 0.035) levels were observed in females than in males in the postabsorptive state. We observed smaller individual differences in miR-122a levels in these animals compared to animals with free access to food, which could be related to smaller individual differences in their metabolic states. This together with reports on multiple transcript variants of miR-122  might explain the variation in miR-122a levels in livers from rats without food restriction. Sequence differences between these variants might be too small for qRT-PCR to discern.
The female-predominant expression of miR-29b and miR-122a observed in this study might be of importance for metabolic control, since these miRNAs were shown to be increased during mild starvation, a condition when the liver switches from anabolic to catabolic pathways. In an as yet unpublished study, we have observed that these mildly starved rats have lower hepatic glycogen content and higher rates of lipid turnover, as compared to the postabsorptive rats. Responses to mild starvation were also observed at the level of hepatic gene expression (unpublished results). However, since most transcript levels were independent of food deprivation, we do not believe that the data presented in figure 3 is a general effect of starvation on gene expression. Increased levels of e.g. miR-29b and miR-122a during starvation might reduce the translatability of key proteins for anabolic processes within the liver.
Among the miRNAs subjected to qRT-PCR, miR-29b was shown to be female-predominant and down-regulated in males given GH treatment. Continuous infusion of GH to male rats has previously been shown to mimic the female-specific endogenous secretion of GH and to partly "feminize" hepatic gene expression in rodents [14–16]. Obviously, miR-29b is not a transcript that is female-predominant due to the female-specific pattern of GH. Interestingly, there are also examples of male-predominant gene products that are induced in male livers upon GH treatment. Those transcripts include spot14, fatty acid synthase and stearoyl-CoA desaturase 1 , which are all involved in de novo lipid synthesis. This is in line with the observation that GH-treated male rats have higher hepatic triglyceride content .
To address the question of a putative biological significance of sex-different hepatic miRNAs, we searched for miRNA targets using the online databases PicTar  and TargetScan [24, 25]. We found that the number of potential targets for different miRNAs differed greatly depending on the database (data not shown). miR-451 had only one predicted target in common between the databases, whereas miR-148a, miR-21 and miR-205 had 200 to 300 putative target genes. Comparing these lists of putative miRNA targets for miR29b or miR-122a towards transcript profiles generated in our lab comparing gene expression in male and female rat livers, no transcripts were in common. Based on a miRNA silencing study of miR-122 in mice, the inconsistency between in silico prediction analysis and in vivo data on miRNA targets is large . This discrepancy between database-generated results and those obtained in biological experiments might be explained by the prediction algorithms used. The algorithms of the two selected databases are based on sequence similarities, so-called seed complementary. Hofacker argues that a thermodynamics-based prediction is a more reliable method than seed complementary to predict miRNA targets . Nevertheless, in vivo studies should always be performed to validate any predicted functions and actions of miRNA.
Combining in silico and in vivo studies, He et al identified a potential miR-29 target, insulin-induced gene 1 (INSIG1, or growth response protein CL-6) . INSIG1 is an endoreticulum-bound protein which inhibits the binding of SREBP to SREBP cleavage-activating protein (SCAP). In the absence of sterols, SCAP binds to SREBPs and mediates their transport from the endoreticulum (ER) to Golgi, where SREBPs are cleaved into their nuclear active form to induce lipid biosynthesis. INSIG1 binds to the sterol sensing domain of SCAP thus inhibiting its binding to SREBPs . We have previously noticed that INSIG1 mRNA , INSIG1 protein, as well as SREBP-1 activation (unpublished data) is highly up-regulated by continuous GH-treatment in male rat livers. Since the main mechanism whereby miRNAs affect protein translatability is to inactivate/degrade the target mRNA, a lower level of miR-29b in response to GH might increase the amount of active/complete INSIG1 mRNA. Further experiments are required to address this.
We have previously shown that hepatic transcript profiles are different between males and females; that some of these differences are under the regulation of GH; and that mild starvation diminishes some of the differences. In this study, we show that hepatic miRNAs are regulated in a similar manner.
Ten weeks old male and female Sprague-Dawley rats (B&K Universal AB) were maintained under standardized conditions. Five male rats were treated with bovine GH (bGH), a kind gift from Pharmacia and Upjohn AB, by continuous infusion from osmotic minipumps (model 2001; B&K Universal AB) at a dose of 5 μg/h. After one week of treatment, the rats were sacrificed and tissues removed and frozen in liquid nitrogen. When the effect of mild starvation was investigated, another group of age-matched male and female rats were used. Food was removed early in the morning (7 a.m.) or late in the evening (11 p.m.), so that the animals were without food 4 hours (postabsorptive) or 12 hours (mild starvation) before they were sacrificed (around noon). Animals were anesthetized, sacrificed, tissues removed and immediately frozen in liquid nitrogen and stored at -80°C until further analysis. All animal experiments were approved by the institutional animal care and use committee.
miRNA-enriched RNA was extracted from liver using miRNeasy Mini kit (Qiagen), according to the manufacturer's protocol. In short, 25 mg of frozen liver was homogenized and extracted using phenol:chloroform. The resulting aqueous phase was mixed with 80% ethanol to extract RNA, followed by precipitation using 100% ethanol and high salt buffers. One of these buffers removes large RNAs (> 200 nucleotides). After a wash using 80% ethanol, miRNA-enriched RNAs were eluted using RNase-free water and quantified by a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc, USA, DE)
Four individual arrays were run for each sex. 3 μg of miRNA-enriched hepatic RNA derived from four males and four females were labeled and hybridized against each other as individual pairs onto the miRCURY™LNA (L ocked N ucleic A cid) microRNA Arrays (208000V8.0, Exiqon, Danmark), according to the manufacturer's protocol. miRNA was considered to be expressed if it was detected in more than 75% of the individual array experiments with a reliable signal (signal to background ratio higher than 1.6). The data were normalized by the algorithm LOWESS using the program R and the significance of any sex-different expression was calculated using the program Significance Analysis of Microarray (SAM). miRNAs identified with a false discovery rate (q-value) lower than 10% and a male to female ratio higher than 1.5 were considered to be significantly sex-different. A p-value was calculated comparing the overall ratio to a value of 1.0, using student's t-test.
Quantitative real-time PCR
Selected miRNAs (miR-122a, miR-29b and miR-451), and 5S rRNA as reference gene, were further examined using the miRCURY™LNA Real-time PCR kit (Exiqon, Danmark), according to the manufacturer's protocol. Briefly, 100 ng miRNA-enriched RNA was reverse-transcribed into cDNA using miRNA-specific primers for miRNA detection or random hexamer for the reference gene. The reverse transcription primer carries an additional sequence complementary to the 3'-end of the PCR primer. Together with a miRNA-specific LNA primer, the synthesized cDNA was amplified and detected by SYBR®Green. Detection and data analysis were performed on Applied Biosystems 7300 Real-Time PCR System and its associated software. Differential expression was determined by delta-delta Ct method that shows the fold changes of samples relative to a reference sample. Individual miRNA (from at least four livers from each animal group) were extracted and analyzed twice. The graphs show the average of at least eight data points for each group and the error bars represent their S.E.
This work was supported by grants from the Swedish Medical Research Council, the Swedish Society of Medical Research, the Family Erling-Persson Foundation and the Center for Gender Medicine at the Karolinska Institutet. We thank Exiqon for providing reagents for real-time PCR reagents and Nana Jacobsen, Nina Ståhlberg and Marie-Louise Lunn from Exiqon for valuable scientific discussions. We also thank Sarah Leigh-Brown at Cancer Research UK for sharing her preliminary findings.
- Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ: miRBase: tools for microRNA genomics. Nucleic acids research. 2008, D154-158. 36 Database 10.1038/sj.emboj.7601977View ArticleGoogle Scholar
- Shyu AB, Wilkinson MF, van Hoof A: Messenger RNA regulation: to translate or to degrade. The EMBO journal. 2008, 27 (3): 471-481. 10.1038/sj.emboj.7601977PubMed CentralView ArticlePubMedGoogle Scholar
- Filipowicz W, Bhattacharyya SN, Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nature reviews. 2008, 9 (2): 102-114.View ArticlePubMedGoogle Scholar
- Tang X, Gal J, Zhuang X, Wang W, Zhu H, Tang G: A simple array platform for microRNA analysis and its application in mouse tissues. RNA. 2007, 13 (10): 1803-1822. 10.1261/rna.498607PubMed CentralView ArticlePubMedGoogle Scholar
- Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002, 12 (9): 735-739. 10.1016/S0960-9822(02)00809-6View ArticlePubMedGoogle Scholar
- Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, et al: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell metabolism. 2006, 3 (2): 87-98. 10.1016/j.cmet.2006.01.005View ArticlePubMedGoogle Scholar
- Mode A, Tollet P, Strom A, Legraverend C, Liddle C, Gustafsson JA: Growth hormone regulation of hepatic cytochrome P450 expression in the rat. Advances in enzyme regulation. 1992, 32: 255-263. 10.1016/0065-2571(92)90021-QView ArticlePubMedGoogle Scholar
- Roy AK, Chatterjee B: Sexual dimorphism in the liver. Annual review of physiology. 1983, 45: 37-50. 10.1146/annurev.ph.45.030183.000345View ArticlePubMedGoogle Scholar
- Waxman DJ, O'Connor C: Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol. 2006, 20 (11): 2613-2629. 10.1210/me.2006-0007View ArticlePubMedGoogle Scholar
- Mode A: Sexually differentiated expression of genes encoding the P4502C cytochromes in rat liver – a model system for studying the action of growth hormone. J Reprod Fertil Suppl. 1993, 46: 77-86.PubMedGoogle Scholar
- Stahlberg N, Rico-Bautista E, Fisher RM, Wu X, Cheung L, Flores-Morales A, Tybring G, Norstedt G, Tollet-Egnell P: Female-Predominant Expression of Fatty Acid Translocase/CD36 in Rat and Human Liver. Endocrinology. 2004, 145 (4): 1972-1979. 10.1210/en.2003-0874View ArticlePubMedGoogle Scholar
- Tollet-Egnell P, Flores-Morales A, Stahlberg N, Malek RL, Lee N, Norstedt G: Gene Expression Profile of the Aging Process in Rat Liver: Normalizing Effects of Growth Hormone Replacement. Mol Endocrinol. 2001, 15 (2): 308-318. 10.1210/me.15.2.308View ArticlePubMedGoogle Scholar
- Tollet-Egnell P, Parini P, Stahlberg N, Lonnstedt I, Lee NH, Rudling M, Flores-Morales A, Norstedt G: Growth hormone-mediated alteration of fuel metabolism in the aged rat as determined from transcript profiles. Physiol Genomics. 2004, 16 (2): 261-267.View ArticlePubMedGoogle Scholar
- Ahluwalia A, Clodfelter KH, Waxman DJ: Sexual Dimorphism of Rat Liver Gene Expression: Regulatory Role of Growth Hormone Revealed by Deoxyribonucleic Acid Microarray Analysis. Mol Endocrinol. 2004, 18 (3): 747-760. 10.1210/me.2003-0138View ArticlePubMedGoogle Scholar
- Mode A, Ahlgren R, Lahuna O, Gustafsson J: Gender differences in rat hepatic CYP2C gene expression – regulation by growth hormone. Growth Horm IGF Res. 1998, 8 (Suppl B): 61-67. 10.1016/S1096-6374(98)80025-7View ArticlePubMedGoogle Scholar
- Srivastava P, Waxman D: Sex-dependent expression and growth hormone regulation of class alpha and class mu glutathione S-transferase mRNAs in adult rat liver. Biochem J. 1993, 294 (Pt 1): 159-165.PubMed CentralView ArticlePubMedGoogle Scholar
- He A, Zhu L, Gupta N, Chang Y, Fang F: Over-expression of miR-29, highly upregulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol. 2007Google Scholar
- Zhan M, Miller CP, Papayannopoulou T, Stamatoyannopoulos G, Song CZ: MicroRNA expression dynamics during murine and human erythroid differentiation. Experimental hematology. 2007, 35 (7): 1015-1025. 10.1016/j.exphem.2007.03.014PubMed CentralView ArticlePubMedGoogle Scholar
- Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007, 133 (2): 647-658. 10.1053/j.gastro.2007.05.022PubMed CentralView ArticlePubMedGoogle Scholar
- Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K: Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. Journal of cellular biochemistry. 2006, 99 (3): 671-678. 10.1002/jcb.20982PubMed CentralView ArticlePubMedGoogle Scholar
- Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, et al: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer research. 2007, 67 (13): 6092-6099. 10.1158/0008-5472.CAN-06-4607View ArticlePubMedGoogle Scholar
- Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, et al: miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA biology. 2004, 1 (2): 106-113.View ArticlePubMedGoogle Scholar
- Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al: Combinatorial microRNA target predictions. Nat Genet. 2005, 37 (5): 495-500. 10.1038/ng1536View ArticlePubMedGoogle Scholar
- Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005, 120 (1): 15-20. 10.1016/j.cell.2004.12.035View ArticlePubMedGoogle Scholar
- Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Molecular cell. 2007, 27 (1): 91-105. 10.1016/j.molcel.2007.06.017PubMed CentralView ArticlePubMedGoogle Scholar
- Hofacker IL: How microRNAs choose their targets. Nat Genet. 2007, 39 (10): 1191-1192. 10.1038/ng1007-1191View ArticlePubMedGoogle Scholar
- Loewen CJ, Levine TP: Cholesterol homeostasis: not until the SCAP lady INSIGs. Curr Biol. 2002, 12 (22): R779-781. 10.1016/S0960-9822(02)01292-7View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.